Mega Genomics Limited

HK$6.89As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6667Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (19.10%)
Div yield 2.54%
ROE 4.03%
Diagnostics & Research
Beta (5Y) 0.76
PE TTM 48.08
TSR TTM —
Mkt cap HK$1.538B
ROIC 9.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.69
(2.97%)
(29.77%)
Hold 0|0|2|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.12
0.11
8.87%
16.37%
17.22%
7.16%
Revenue¥M
98.26
95.73
98.36
103.9
6.75%
0.73%
3.91%
3.68%
Peers (US$196.3M)
Cap (US$)
PE
198.0M
38.95x
Capital
TTM
5Y
10Y
Leveragex
0.829
0.283
0.225
EBIT/Intx
0.680
0.348
0.340
Own earn%
363.19
(169.13)
(163.39)
Sh yield%
35.49
11.84
11.95
Owners
Insiders/Inst%
10.53
60.82
Short interest%
5.84
SBC / revenue%
3.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
18–27
$1 testx
0.0
Incr. ROIC%
33